Internal Medicine, Hematology & Oncology · Montgomery, OH
NPI
1053586420
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
10506a Montgomery Rd
Montgomery, OH, 45242
Phone (513) 853-1300
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
1,706 services
Medicare patients, 2024
356
Average age 74
Drug cost, 2024
$11.2M
2,740 prescriptions
Company payments, 2025
$123K
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saulius K Girnius was code 99215 (office e&m - established), 650 times for 132 patients. In total Saulius K Girnius billed 1,706 services in 19 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 650 | 132 | $105.61 | $69K |
| 99215 Office E&M - Established | Facility | 283 | 44 | $105.95 | $30K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 205 | 109 | $12.91 | $2,647 |
| 99213 Office E&M - Established | Office | 187 | 103 | $44.08 | $8,244 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 68 | 31 | $12.91 | $878 |
| 99233 Hospital E&M - Subsequent | Facility | 62 | 30 | $90.75 | $5,626 |
| 99214 Office E&M - Established | Office | 57 | 51 | $69.14 | $3,941 |
| 99223 Hospital E&M - Initial | Facility | 48 | 46 | $134.07 | $6,436 |
| 99213 Office E&M - Established | Facility | 32 | 20 | $46.73 | $1,495 |
| 99222 Hospital E&M - Initial | Facility | 29 | 28 | $102.09 | $2,961 |
By year: 2022 $165K for 1,579 services; 2023 $137K for 1,451 services; 2024 $136K for 1,706 services.
Medicare prescription drug claims, 2024
In 2024, the drug Saulius K Girnius prescribed most often to Medicare patients was Acyclovir, with 360 prescriptions and refills. In total Saulius K Girnius wrote 2,740 Medicare prescriptions that cost $11.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 360 | 482 | 89 | $4,528 |
| Revlimid Lenalidomide | 152 | 152 | 35 | $2.6M |
| Lenalidomide Generic | 141 | 141 | 35 | $1.9M |
| Dexamethasone Generic | 138 | 165 | 59 | $1,841 |
| Brukinsa Zanubrutinib | 133 | 133 | 14 | $1.7M |
| Venclexta Venetoclax | 131 | 133 | 27 | $1.0M |
| Eliquis Apixaban | 127 | 184 | 25 | $104K |
| Prochlorperazine Maleate Generic | 82 | 82 | 54 | $1,296 |
| Prednisone Generic | 78 | 86 | 27 | $317 |
| Xarelto Rivaroxaban | 70 | 91 | 15 | $50K |
| Levofloxacin Generic | 69 | 71 | 32 | $675 |
| Ondansetron Hcl Generic | 57 | 58 | 26 | $846 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 55 | 79 | 17 | $199 |
| Ninlaro Ixazomib Citrate | 55 | 55 | Under 11 | $709K |
| Oxycodone Hcl Generic | 53 | 53 | 19 | $841 |
Brand drugs: - claims; generic drugs: 1,870 claims; opioid claims: 107.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saulius K Girnius $123K ($123K in general payments such as food, travel and fees and $950 for research) from 32 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $47K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 23 | $47K |
| Janssen Biotech, Inc. JNJ | 17 | $26K |
| Pfizer Inc. PFE | 10 | $12K |
| Kite Pharma, Inc. GILD | 12 | $11K |
| BeOne Medicines USA, Inc. ONC | 6 | $9,974 |
| Syndax Pharmaceuticals, Inc. SNDX | 6 | $4,484 |
| Amgen Inc. AMGN | 1 | $3,864 |
| Genentech USA, Inc. ROG.SW | 3 | $2,461 |
| Genzyme Corporation SNY | 5 | $2,122 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $1,980 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.